By Forbes |
July 13, 2020
The painful blood disorder, which mostly affects Black people, is just one of thousands of rare diseases that could be cured by Beam Therapeutics' revolutionary gene editing technology.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
A new personal protective equipment manufacturing company is set to open in Cincinnati next year.